BioIVT in October named Lori Ball as its chief operating officer (COO), a role in which she will help lead the company’s operational and business decisions.
“I have a deep passion for life science and research because I have personally witnessed the impact of such developments on my friends and family,” Ball told us.
“BioIVT has been instrumental to many scientific breakthroughs and I am humbled to become a part of such a well-established industry leader. I am looking forward to building upon BioIVT’s strategic vision to positively impact treatment outcomes and improve human health.”
Ball was previously the president and CEO of the business strategy consultancy in the life sciences industry, LAB Strategies. Prior to that, she was president and COO of BioStorage Technologies and worked at Covance for seven years. She also co-founded of The Global Initiative for the Ethical use of Human Specimens (the GIFT Initiative).